Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2015, Article ID 857316, 6 pages
http://dx.doi.org/10.1155/2015/857316
Research Article

Clinicopathological Correlation in Asian Patients with Biopsy-Proven Lupus Nephritis

Division of Nephrology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok 10400, Thailand

Received 8 January 2015; Revised 5 March 2015; Accepted 5 March 2015

Academic Editor: Richard Fatica

Copyright © 2015 Bancha Satirapoj et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Cervera, M. A. Khamashta, J. Font et al., “Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients,” Medicine, vol. 82, no. 5, pp. 299–308, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Satirapoj, J. Wongchinsri, N. Youngprang et al., “Predictors of renal involvement in patients with systemic lupus erythematosus,” Asian Pacific Journal of Allergy and Immunology, vol. 25, no. 1, pp. 17–25, 2007. View at Google Scholar · View at Scopus
  3. F. Yu, Y. Tan, L.-H. Wu, S.-N. Zhu, G. Liu, and M.-H. Zhao, “Class IV-G and IV-S lupus nephritis in Chinese patients: a large cohort study from a single center,” Lupus, vol. 18, no. 12, pp. 1073–1081, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. K. I. Dibbs, Y. Sadovsky, X.-J. Li, S. S. Koide, S. Adler, and A.-R. Fuchs, “Estrogenic activity of RU 486 (mifepristone) in rat uterus and cultured uterine myocytes,” American Journal of Obstetrics and Gynecology, vol. 173, no. 1, pp. 134–140, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. J. J. Weening, V. D. D'Agati, M. M. Schwartz et al., “The classification of glomerulonephritis in systemic lupus erythematosus revisited,” Journal of the American Society of Nephrology, vol. 15, no. 2, pp. 241–250, 2004. View at Google Scholar
  6. Z. Shariati-Sarabi, A. Ranjbar, S. M. Monzavi, H. Esmaily, M. Farzadnia, and A. A. Zeraati, “Analysis of clinicopathologic correlations in Iranian patients with lupus nephritis,” International Journal of Rheumatic Diseases, vol. 16, no. 6, pp. 731–738, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Chen, Z. Tang, Y. Zhang, Z. Liu, H. Zhang, and W. Hu, “Significance of histological crescent formation in patients with diffuse proliferative lupus nephritis,” American Journal of Nephrology, vol. 38, no. 6, pp. 445–452, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Parichatikanond, N. D. Francis, P. Malasit et al., “Lupus nephritis: clinicopathological study of 162 cases in Thailand,” Journal of Clinical Pathology, vol. 39, no. 2, pp. 160–166, 1986. View at Publisher · View at Google Scholar · View at Scopus
  9. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 9, p. 1725, 1997. View at Google Scholar · View at Scopus
  10. H. A. Austin III, L. R. Muenz, K. M. Joyce et al., “Prognostic factors in lupus nephritis. Contribution of renal histologic data,” The American Journal of Medicine, vol. 75, no. 3, pp. 382–391, 1983. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Faurschou, H. Starklint, P. Halberg, and S. Jacobsen, “Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure,” Journal of Rheumatology, vol. 33, no. 8, pp. 1563–1569, 2006. View at Google Scholar · View at Scopus
  12. I. G. Okpechi, C. R. Swanepoel, N. Tiffin, M. Duffield, and B. L. Rayner, “Clinicopathological insights into lupus nephritis in South Africans: a study of 251 patients,” Lupus, vol. 21, no. 9, pp. 1017–1024, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Nasri, A. Ahmadi, A. Baradaran et al., “Clinicopathological correlations in lupus nephritis; a single center experience,” Journal of Nephropathology, vol. 3, no. 3, pp. 115–120, 2014. View at Publisher · View at Google Scholar
  14. F. Mitjavila, V. Pac, I. Moga et al., “Clinicopathological correlations and prognostic factors in lupus nephritis,” Clinical and Experimental Rheumatology, vol. 15, no. 6, pp. 625–631, 1997. View at Google Scholar · View at Scopus
  15. Q. Chen, Z. Liu, W. Hu, H. Chen, C. Zeng, and L. Li, “Class V lupus nephritis: a clinicopathologic study in 152 patients,” Journal of Nephrology, vol. 16, no. 1, pp. 126–132, 2003. View at Google Scholar · View at Scopus
  16. S. Emre, I. Bilge, A. Sirin et al., “Lupus nephritis in children: prognostic significance of clinicopathological findings,” Nephron, vol. 87, no. 2, pp. 118–126, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. A. J. Howie, N. Turhan, and D. Adu, “Powerful morphometric indicator of prognosis in lupus nephritis,” QJM, vol. 96, no. 6, pp. 411–420, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. B. H. Rovin and S. V. Parikh, “Lupus nephritis: the evolving role of novel therapeutics,” The American Journal of Kidney Diseases, vol. 63, no. 4, pp. 677–690, 2014. View at Publisher · View at Google Scholar · View at Scopus